Deciphera Pharma
Edit

Deciphera Pharma

http://www.deciphera.com/
Tags:DrugFamilyInformationLivingPharmacyPlatformProduct
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Australia, Canada, Hong Kong, and China. For more information, visit www.deciphera.com.
Likes
191
Location: United States, Massachusetts, Waltham
Member count: 201-500
Phone: +1 781-209-6400
Total raised: $127M
Founded date: 2003

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
01.06.2017Series C$52M-finsmes.co...
21.09.2015Series B$75M-medcitynew...

Mentions in press and media 24

DateTitleDescriptionCategoryAuthorSource
17.09.2021Deciphera ...Deciphera Announces Positive C...--marketscre...
23.11.2020The Boston...WALTHAM, Mass.--(BUSINESS WIRE...--svhealthin...
22.06.2020Deciphera ...June 22, 2020 at 7:00 AM EDTPD...--svhealthin...
08.06.2020Deciphera ...June 8, 2020 at 7:30 AM EDTPDF...--svhealthin...
29.05.2020Deciphera ...Patients Receiving QINLOCK for...--svhealthin...
16.12.2019Deciphera ...– Application is Being Reviewe...--svhealthin...
28.10.2019FDA to spl...Shares of Blueprint were down ...--medcitynew...
28.09.2017Term Sheet...DIAL UP THE DRAMA Good mornin...--fortune.co...
19.09.2017Term Sheet...VCs VERSUS ICOs Companies hav...--fortune.co...
05.09.2017Term Sheet...CATCH UP Good morning, Term S...--fortune.co...
Show more